Defunct Company
Total Trials
17
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,481
NCT00034710
Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2002
Completion: Oct 31, 2002
NCT00064623
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
Phase: Phase 3
Start: Aug 31, 2003
Completion: Nov 30, 2005
NCT00115310
Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
Start: Jun 30, 2005
Completion: Oct 31, 2006
NCT00233155
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)
Start: Aug 31, 2005
Completion: Dec 31, 2006
NCT00254449
Effect of NGX-4010 on ENFD and Sensory Function
Phase: Phase 1
Start: Nov 30, 2005
Completion: May 31, 2006
NCT00300222
Start: Mar 31, 2006
Completion: Aug 31, 2007
NCT00321672
Start: Jun 30, 2006
Completion: Dec 31, 2007
NCT00912262
A Study to Investigate the Tolerability and Effects on Epidermal Nerve Fiber Density of Multiple Low-Concentrations of NGX-1998 in Healthy Volunteers
Start: Jun 30, 2008
Completion: Nov 30, 2008
NCT00916942
Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)
Start: Jun 30, 2009
Completion: Jul 31, 2009
NCT01228838
Study of NGX-1998 for the Treatment of Postherpetic Neuralgia
Start: Oct 31, 2010
Completion: Sep 30, 2011